Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Parkinsons Dis. 2012 Jan 1;2(1):57–65. doi: 10.3233/JPD-2012-11073

Figure 1.

Figure 1

A) Representative images taken at 10× magnification of plaque density scores in the putamen of none (0), sparse (1), moderate (2) and frequent (3), according to the published CERAD criteria [1]. B) Representative images taken at 40× magnification of neuritic (white arrow) and diffuse plaques (green arrow) with Thioflavine-S and Campbell-Switzer staining.